Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Small Molecule CMO/CDMO Market Set To Climb From $58.55 Billion In 2026 To $78.4 Billion By 2030
The small molecule cmo/cdmo market size has experienced robust expansion in recent times. This market is projected to expand from $54.42 billion in 2025 to $58.55 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.6%. Historically, this growth can be ascribed to several factors, including the increase in generic drug manufacturing, the growing incidence of chronic diseases, the broader scope of pharmaceutical R&D, the outsourcing of drug production, and a regulatory emphasis on quality and safety.
The small molecule cmo/cdmo market size is projected to experience substantial growth in the upcoming years. It is forecast to expand to $78.41 billion in 2030, driven by a compound annual growth rate (CAGR) of 7.6%. The expansion during this period can be attributed to several factors including the rising demand for personalized medicine, increased investments in biologics and small-molecule hybrid therapies, the spread into emerging markets, advancements in synthesis and formulation technologies, and the growing requirement for expedited regulatory approvals. Significant trends expected in the forecast period include the widening scope of contract development and manufacturing services, greater adoption of continuous manufacturing processes, an increase in the custom synthesis of small-molecule APIs, an intensified focus on regulatory compliance and quality assurance, and strategic collaborations between pharmaceutical companies and CMOs.
Get A Free Sample Report With In-Depth Market Insights:
Small Molecule CMO/CDMO Market Growth Backed By Core Demand Fundamentals
The increasing need for pharmaceutical products is anticipated to boost the expansion of the small-molecule CMO/CDMO market in the future. This sector, known as the pharmaceutical industry, encompasses the finding, creation, and manufacturing of medications and drugs by both public and private organizations. Within the pharmaceutical industry, small-molecule CMO/CDMO facilities are utilized to externalize diverse services, such as the formulation, production, and packaging of small-molecule medicines, thereby enabling pharmaceutical firms to decrease expenses, conserve duration, and optimize workflows. To illustrate, in January 2023, data from Cardinal Health Inc., a US-based healthcare company, indicated that by January 2022, the U.S. had 33 biosimilar products approved by the FDA, with 21 of them available on the market, and this figure climbed to 40 FDA-approved biosimilars by 2023, with 25 becoming commercially accessible. Consequently, the growing requirement for pharmaceuticals is fueling the expansion of the small-molecule CMO/CDMO market.
Small Molecule CMO/CDMO Market Segmentation: How Does The Market Break Down By Category?
The small molecule cmo/cdmo market covered in this report is segmented –
1) By Product: Small Molecule Drug Product, Small Molecule API
2) By Stage Type: Clinical, Commercial, Preclinical
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics
4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders
Subsegments:
1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms
2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs
Small Molecule CMO/CDMO Market Growth Trends Reshaping The Competitive Landscape
Major companies operating in the small-molecule CMO/CDMO market are increasingly focusing on advanced technologies, such as the sophisticated small-molecule platform in Shanghai, to improve CDMO services. This state-of-the-art small-molecule platform represents the forefront of technological advancements for developing and producing small-molecule drugs, aiming to create pharmaceutical compounds that are safer, more effective, and more efficiently manufactured. For example, in June 2023, Porton Pharma Solutions Ltd., a pharmaceutical company based in China, launched a state-of-the-art small-molecule platform in Shanghai, which enhanced its CDMO services. An advanced small molecule platform embodies a comprehensive strategy, combining cutting-edge technologies and methodologies to advance the entire lifecycle of small molecule pharmaceuticals, offering one-stop-shop solutions, an end-to-end platform, flexibility and availability, and digital transformation.
Small Molecule CMO/CDMO Market Competitive Overview And Top Companies
Major companies operating in the small molecule cmo/cdmo market are Patheon NV (Thermo Fisher Scientific), Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services
View The Full Small Molecule CMO/CDMO Market Report:
Small Molecule CMO/CDMO Market Geographic Analysis: Where Is Demand Accelerating Fastest?
North America was the largest region in the small molecule CMO/CDMO market in 2025. The regions covered in the small molecule cmo/cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model